A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer
Umberto Veronesi, M.D., Giovanni Paganelli, M.D., Giuseppe Viale, F.R.C.Path., Alberto Luini, M.D., Stefano Zurrida, M.D., Viviana Galimberti, M.D., Mattia Intra, M.D., Paolo Veronesi, M.D., Chris Robertson, Ph.D., Patrick Maisonneuve, Eng., Giuseppe Renne, M.D., Concetta De Cicco, M.D., Francesca De Lucia, M.D., and Roberto Gennari, M.D.
Background Although numerous studies have shown that the statusof the sentinel node is an accurate predictor of the statusof the axillary nodes in breast cancer, the efficacy and safetyof sentinel-node biopsy require validation.
From the Divisions of Senology (U.V., A.L., S.Z., V.G., M.I., P.V., R.G.), Nuclear Medicine (G.P., C.D.), Pathology (G.V., G.R.), Epidemiology (C.R., P.M.), and Anaesthesiology (F.D.), European Institute of Oncology; and the University of Milan School of Medicine (G.V.) both in Milan, Italy.
Address reprint requests to Dr. Umberto Veronesi at the Istituto Europeo di Oncologia, Via G. Ripamonti 435, 20141 Milan, Italy, or at umberto.veronesi{at}ieo.it.
Sentinel-Node Biopsy in Breast Cancer
Badwe R. A., Thorat M. A., Parmar V. V., De Salvo G. L., Del Bianco P., Zavagno G., Munster A. M., McMasters K. M., Veronesi U., Maisonneuve P., Krag D., Ashikaga T.
Extract |
Full Text |
PDF
N Engl J Med 2003;
349:1968-1971, Nov 13, 2003.
Correspondence
This article has been cited by other articles:
Bilimoria, K. Y., Bentrem, D. J., Hansen, N. M., Bethke, K. P., Rademaker, A. W., Ko, C. Y., Winchester, D. P., Winchester, D. J.
(2009). Comparison of Sentinel Lymph Node Biopsy Alone and Completion Axillary Lymph Node Dissection for Node-Positive Breast Cancer. JCO
27: 2946-2953
[Abstract][Full Text]
Spillane, A. J., Noushi, F., Cooper, R. A., Gebski, V., Uren, R. F.
(2009). High-resolution lymphoscintigraphy is essential for recognition of the significance of internal mammary nodes in breast cancer. Ann Oncol
20: 977-984
[Abstract][Full Text]
Gadd, M.
(2009). Sentinel lymph node biopsy for staging early breast cancer: minimizing the trade-off by maximizing the accuracy. Ann Oncol
20: 973-975
[Full Text]
Canavese, G., Catturich, A., Vecchio, C., Tomei, D., Gipponi, M., Villa, G., Carli, F., Bruzzi, P., Dozin, B.
(2009). Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial. Ann Oncol
20: 1001-1007
[Abstract][Full Text]
Doyle, B, Al-Mudhaffer, M, Kennedy, M M, O'Doherty, A, Flanagan, F, McDermott, E W, Kerin, M J, Hill, A D, Quinn, C M
(2009). Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?. J. Clin. Pathol.
62: 534-538
[Abstract][Full Text]
Dabakuyo, T. S., Fraisse, J., Causeret, S., Gouy, S., Padeano, M.-M., Loustalot, C., Cuisenier, J., Sauzedde, J.-M., Smail, M., Combier, J.-P., Chevillote, P., Rosburger, C., Boulet, S., Arveux, P., Bonnetain, F.
(2009). A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissection. Ann Oncol
0: mdp016v1-mdp016
[Abstract][Full Text]
Kataja, V., Castiglione, M., On behalf of the ESMO Guidelines Working Group,
(2009). Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol
20: iv10-iv14
[Full Text]
Leijte, J. A.P., van der Ploeg, I. M.C., Valdes Olmos, R. A., Nieweg, O. E., Horenblas, S.
(2009). Visualization of Tumor Blockage and Rerouting of Lymphatic Drainage in Penile Cancer Patients by Use of SPECT/CT. JNM
50: 364-367
[Abstract][Full Text]
CRAWSHAW, J W, HADWAY, P, HOFFLAND, D, BASSINGHAM, S, CORBISHLEY, C M, SMITH, Y, PILCHER, J, ALLAN, R, WATKIN (Urol), N A, HEENAN, S D
(2009). Sentinel lymph node biopsy using dynamic lymphoscintigraphy combined with ultrasound-guided fine needle aspiration in penile carcinoma. Br. J. Radiol.
82: 41-48
[Abstract][Full Text]
Lyman, G. H., Van Zee, K. J., Edge, S. B.
(2009). Impact and Remaining Challenges in the Use of Sentinel Lymph Node Biopsy in Early-stage Breast Cancer. Am Soc Clin Oncol Ed Book
2009: 346-353
[Abstract][Full Text]
Mittendorf, E. A., Sahin, A. A., Tucker, S. L., Meric-Bernstam, F., Yi, M., Nayeemuddin, K. M., Babiera, G. V., Ross, M. I., Feig, B. W., Kuerer, H. M., Hunt, K. K.
(2008). Lymphovascular Invasion and Lobular Histology are Associated with Increased Incidence of Isolated Tumor Cells in Sentinel Lymph Nodes from Early-Stage Breast Cancer Patients. Ann. Surg. Oncol.
15: 3369-3383
[Abstract][Full Text]
van Deurzen, C. H. M., de Boer, M., Monninkhof, E. M., Bult, P., van der Wall, E., Tjan-Heijnen, V. C. G., van Diest, P. J.
(2008). Non-Sentinel Lymph Node Metastases Associated With Isolated Breast Cancer Cells in the Sentinel Node. JNCI J Natl Cancer Inst
100: 1574-1580
[Abstract][Full Text]
McLaughlin, S. A., Wright, M. J., Morris, K. T., Giron, G. L., Sampson, M. R., Brockway, J. P., Hurley, K. E., Riedel, E. R., Van Zee, K. J.
(2008). Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective Measurements. JCO
26: 5213-5219
[Abstract][Full Text]
McLaughlin, S. A., Wright, M. J., Morris, K. T., Sampson, M. R., Brockway, J. P., Hurley, K. E., Riedel, E. R., Van Zee, K. J.
(2008). Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Patient Perceptions and Precautionary Behaviors. JCO
26: 5220-5226
[Abstract][Full Text]
Pandharipande, P. V., Harisinghani, M. G., Ozanne, E. M., Specht, M. C., Hur, C., Lee, J. M., Gazelle, G. S.
(2008). Staging MR Lymphangiography of the Axilla for Early Breast Cancer: Cost-Effectiveness Analysis. Am. J. Roentgenol.
191: 1308-1319
[Abstract][Full Text]
Poletti, P., Fenaroli, P., Milesi, A., Paludetti, A., Mangiarotti, S., Virotta, G., Candiago, E., Bettini, A., Caremoli, E. R., Labianca, R., Tondini, C.
(2008). Axillary recurrence in sentinel lymph node-negative breast cancer patients. Ann Oncol
19: 1842-1846
[Abstract][Full Text]
Kawai, Y., Kaidoh, M., Ohhashi, T.
(2008). MDA-MB-231 produces ATP-mediated ICAM-1-dependent facilitation of the attachment of carcinoma cells to human lymphatic endothelial cells. Am. J. Physiol. Cell Physiol.
295: C1123-C1132
[Abstract][Full Text]
Kootstra, J., Hoekstra-Weebers, J. E. H. M., Rietman, H., de Vries, J., Baas, P., Geertzen, J. H. B., Hoekstra, H. J.
(2008). Quality of Life After Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection in Stage I/II Breast Cancer Patients: A Prospective Longitudinal Study. Ann. Surg. Oncol.
15: 2533-2541
[Abstract][Full Text]
Perhavec, A., Besic, N., Hocevar, M., Zgajnar, J.
(2008). Touch Imprint Cytology of the Sentinel Lymph Nodes Might Not Be Indicated in Early Breast Cancer Patients with Ultrasonically Uninvolved Axillary Lymph Nodes. Ann. Surg. Oncol.
15: 2257-2262
[Abstract][Full Text]
Bear, H. D.
(2008). Completion Axillary Lymph Node Dissection for Breast Cancer: Immediate Versus Delayed Versus None. JCO
26: 3483-3484
[Full Text]
Olson, J. A. Jr, McCall, L. M., Beitsch, P., Whitworth, P. W., Reintgen, D. S., Blumencranz, P. W., Leitch, A. M., Saha, S., Hunt, K. K., Giuliano, A. E.
(2008). Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011. JCO
26: 3530-3535
[Abstract][Full Text]
Crane-Okada, R., Wascher, R. A., Elashoff, D., Giuliano, A. E.
(2008). Long-Term Morbidity of Sentinel Node Biopsy Versus Complete Axillary Dissection for Unilateral Breast Cancer. Ann. Surg. Oncol.
15: 1996-2005
[Abstract][Full Text]
Altgassen, C., Hertel, H., Brandstadt, A., Kohler, C., Durst, M., Schneider, A.
(2008). Multicenter Validation Study of the Sentinel Lymph Node Concept in Cervical Cancer: AGO Study Group. JCO
26: 2943-2951
[Abstract][Full Text]
Shimazu, K., Tamaki, Y., Taguchi, T., Tsukamoto, F., Kasugai, T., Noguchi, S.
(2008). Intraoperative Frozen Section Analysis of Sentinel Lymph Node in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Ann. Surg. Oncol.
15: 1717-1722
[Abstract][Full Text]
Yang, S. H., Yang, K. H., Li, Y. P., Zhang, Y. C., He, X. D., Song, A. L., Tian, J. H., Jiang, L., Bai, Z. G., He, L. F., Liu, Y. L., Ma, B.
(2008). Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials. Ann Oncol
19: 1039-1044
[Abstract][Full Text]
Samphao, S., Eremin, J. M., El-Sheemy, M., Eremin, O.
(2008). Management of the Axilla in Women With Breast Cancer: Current Clinical Practice and a New Selective Targeted Approach. Ann. Surg. Oncol.
15: 1282-1296
[Abstract][Full Text]
Intra, M., Garcia-Etienne, C. A., Renne, G., Trifiro, G., Rotmensz, N., Gentilini, O. D., Galimberti, V., Sagona, A., Mattar, D., Sangalli, C., Gatti, G., Luini, A., Veronesi, U.
(2008). When Sentinel Lymph Node is Intramammary. Ann. Surg. Oncol.
15: 1304-1308
[Abstract][Full Text]
Tan, L. K., Giri, D., Hummer, A. J., Panageas, K. S., Brogi, E., Norton, L., Hudis, C., Borgen, P. I., Cody, H. S. III
(2008). Occult Axillary Node Metastases in Breast Cancer Are Prognostically Significant: Results in 368 Node-Negative Patients With 20-Year Follow-Up. JCO
26: 1803-1809
[Abstract][Full Text]
van der Ploeg, I. M. C., Kroon, B. B. R., Antonini, N., Olmos, R. A. V., Rutgers, E. J. T., Nieweg, O. E.
(2008). Axillary and Extra-axillary Lymph Node Recurrences after a Tumor-Negative Sentinel Node Biopsy for Breast Cancer Using Intralesional Tracer Administration. Ann. Surg. Oncol.
15: 1025-1031
[Abstract][Full Text]
Fink, A. M., Lass, H., Hartleb, H., Jurecka, W., Salzer, H., Steiner, A.
(2008). S-Classification of Sentinel Lymph Node Predicts Axillary Nonsentinel Lymph Node Status in Patients with Breast Cancer. Ann. Surg. Oncol.
15: 848-853
[Abstract][Full Text]
Somasundaram, S. K., Chicken, D. W., Keshtgar, M. R. S.
(2008). Detection of the sentinel lymph node in breast cancer. Br Med Bull
0: ldm032v1-15
[Abstract][Full Text]
Arora, N., Martins, D., Huston, T. L., Christos, P., Hoda, S., Osborne, M. P., Swistel, A. J., Tousimis, E., Pressman, P. I., Simmons, R. M.
(2008). Sentinel Node Positivity Rates With and Without Frozen Section for Breast Cancer. Ann. Surg. Oncol.
15: 256-261
[Abstract][Full Text]
Goyal, A., Newcombe, R. G., Chhabra, A., Mansel, R. E.
(2008). Morbidity in Breast Cancer Patients with Sentinel Node Metastases Undergoing Delayed Axillary Lymph Node Dissection (ALND) Compared with Immediate ALND. Ann. Surg. Oncol.
15: 262-267
[Abstract][Full Text]
Nathanson, S. D., Burke, M., Slater, R., Kapke, A.
(2007). Preoperative Identification of the Sentinel Lymph Node in Breast Cancer. Ann. Surg. Oncol.
14: 3102-3110
[Abstract][Full Text]
Yamauchi, C., Mitsumori, M., Sai, H., Imagunbai, T., Negoro, Y., Sasaki, Y., Hiraoka, M., Shikama, N., Sasaki, S., Takegawa, H., Inoue, T., Teshima, T.
(2007). Patterns of Care Study of Breast-conserving Therapy in Japan: Comparison of the Treatment Process between 1995 1997 and 1999 2001 Surveys. Jpn J Clin Oncol
0: hym096v1-7
[Abstract][Full Text]
Colleoni, M., Rotmensz, N., Maisonneuve, P., Sonzogni, A., Pruneri, G., Casadio, C., Luini, A., Veronesi, P., Intra, M., Galimberti, V., Torrisi, R., Andrighetto, S., Ghisini, R., Goldhirsch, A., Viale, G.
(2007). Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol
18: 1632-1640
[Abstract][Full Text]
Gervasoni, J. E. Jr., Sbayi, S., Cady, B.
(2007). Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data.. Ann. Surg. Oncol.
14: 2443-2462
[Abstract][Full Text]
Nos, C., Lesieur, B., Clough, K. B., Lecuru, F.
(2007). Blue Dye Injection in the Arm in Order to Conserve the Lymphatic Drainage of the Arm in Breast Cancer Patients Requiring an Axillary Dissection. Ann. Surg. Oncol.
14: 2490-2496
[Abstract][Full Text]
Bevilacqua, J. L. B., Kattan, M. W., Fey, J. V., Cody, H. S. III, Borgen, P. I., Van Zee, K. J.
(2007). Doctor, What Are My Chances of Having a Positive Sentinel Node? A Validated Nomogram for Risk Estimation. JCO
25: 3670-3679
[Abstract][Full Text]
Nakagawa, T., Martinez, S. R., Goto, Y., Koyanagi, K., Kitago, M., Shingai, T., Elashoff, D. A., Ye, X., Singer, F. R., Giuliano, A. E., Hoon, D. S.B.
(2007). Detection of Circulating Tumor Cells in Early-Stage Breast Cancer Metastasis to Axillary Lymph Nodes. Clin. Cancer Res.
13: 4105-4110
[Abstract][Full Text]
Langer, I., Guller, U., Koechli, O. R., Berclaz, G., Singer, G., Schaer, G., Fehr, M. K., Hess, T., Oertli, D., Bronz, L., Schnarwyler, B., Wight, E., Uehlinger, U., Infanger, E., Burger, D., Zuber, M., for the Swiss Multicenter Sentinel Lymph Node Stud,
(2007). Association of the Presence of Bone Marrow Micrometastases with the Sentinel Lymph Node Status in 410 Early Stage Breast Cancer Patients: Results of the Swiss Multicenter Study. Ann. Surg. Oncol.
14: 1896-1903
[Abstract][Full Text]
Nathanson, S. D., Grogan, J. K., DeBruyn, D., Kapke, A., Karvelis, K.
(2007). Breast Cancer Sentinel Lymph Node Identification Rates: The Influence of Radiocolloid Mapping, Case Volume, and the Place of the Procedure. Ann. Surg. Oncol.
14: 1629-1637
[Abstract][Full Text]
Gentilini, O., Chagas, E., Zurrida, S., Intra, M., De Cicco, C., Gatti, G., Silva, L., Renne, G., Cassano, E., Veronesi, U.
(2007). Sentinel Lymph Node Biopsy in Male Patients with Early Breast Cancer. The Oncologist
12: 512-515
[Abstract][Full Text]
Barros, A. C. S. D., Barros, M. A. C., Andrade, F. E., Mori, L. J., Costa, P. A., Sheng, P. Y., Pelizon, C. H. T.
(2007). Combined Radioguided Nonpalpable Lesion Localization and Sentinel Lymph Node Biopsy for Early Breast Carcinoma. Ann. Surg. Oncol.
14: 1472-1477
[Abstract][Full Text]
Dauphine, C. E., Haukoos, J. S., Vargas, M. P., Isaac, N. M., Khalkhali, I., Vargas, H. I.
(2007). Evaluation of Three Scoring Systems Predicting Non Sentinel Node Metastasis in Breast Cancer Patients with a Positive Sentinel Node Biopsy. Ann. Surg. Oncol.
14: 1014-1019
[Abstract][Full Text]
Veronesi, U, De Cicco, C, Galimberti, V., Fernandez, J., Rotmensz, N, Viale, G, Spano, G, Luini, A, Intra, M, Veronesi, P, Berrettini, A, Paganelli, G
(2007). A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol
18: 473-478
[Abstract][Full Text]
Smidt, M. L., Strobbe, L. J. A., Groenewoud, H. M. M., der Wilt, G. J., Van Zee, K. J., Wobbes, T.
(2007). Can Surgical Oncologists Reliably Predict the Likelihood for Non-SLN Metastases in Breast Cancer Patients?. Ann. Surg. Oncol.
14: 615-620
[Abstract][Full Text]
Lelievre, L., Houvenaeghel, G., Buttarelli, M., Brenot-Rossi, I., Huiart, L., Tallet, A., Tarpin, C., Jacquemier, J.
(2007). Value of the Sentinel Lymph Node Procedure in Patients With Large Size Breast Cancer. Ann. Surg. Oncol.
14: 621-626
[Abstract][Full Text]
Shimizu, C., Ando, M., Kouno, T., Katsumata, N., Fujiwara, Y.
(2007). Current Trends and Controversies over Pre-operative Chemotherapy for Women with Operable Breast Cancer. Jpn J Clin Oncol
0: hyl122v1-8
[Abstract][Full Text]
Gilligan, M. A., Neuner, J., Sparapani, R., Laud, P. W., Nattinger, A. B.
(2007). Surgeon Characteristics and Variations in Treatment for Early-Stage Breast Cancer. Arch Surg
142: 17-22
[Abstract][Full Text]
Nakagawa, T., Huang, S. K., Martinez, S. R., Tran, A. N., Elashoff, D., Ye, X., Turner, R. R., Giuliano, A. E., Hoon, D. S.B.
(2006). Proteomic Profiling of Primary Breast Cancer Predicts Axillary Lymph Node Metastasis. Cancer Res.
66: 11825-11830
[Abstract][Full Text]
Bolster, M. J., Bult, P., Schapers, R. F. M., Meijer, J. W. R., Strobbe, L. J. A., van Berlo, C. L. H., Klinkenbijl, J. H. G., Peer, P. G. M., Wobbes, T., Tjan-Heijnen, V. C. G.
(2006). Differences in Sentinel Lymph Node Pathology Protocols Lead to Differences in Surgical Strategy in Breast Cancer Patients. Ann. Surg. Oncol.
13: 1466-1473
[Abstract][Full Text]
Blancas, I, Garcia-Puche, J., Bermejo, B, Hanrahan, E., Monteagudo, C, Martinez-Agullo, A, Rouzier, R, Hennessy, B., Valero, V, Lluch, A
(2006). Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor. Ann Oncol
17: 1644-1649
[Abstract][Full Text]
Colleoni, M, Rotmensz, N, Peruzzotti, G, Maisonneuve, P, Orlando, L, Ghisini, R, Viale, G, Pruneri, G, Veronesi, P, Luini, A, Intra, M, Cardillo, A, Torrisi, R, Rocca, A, Goldhirsch, A
(2006). Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease. Ann Oncol
17: 1497-1503
[Abstract][Full Text]
Chen, S. L., Iddings, D. M., Scheri, R. P., Bilchik, A. J.
(2006). Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications. CA Cancer J Clin
56: 292-309
[Abstract][Full Text]
Taback, B., Nguyen, P., Hansen, N., Edwards, G. K., Conway, K., Giuliano, A. E.
(2006). Sentinel Lymph Node Biopsy for Local Recurrence of Breast Cancer After Breast-Conserving Therapy. Ann. Surg. Oncol.
13: 1099-1104
[Abstract][Full Text]
Pater, J., Parulekar, W.
(2006). Sentinel lymph node biopsy in early breast cancer: has its time come?. JNCI J Natl Cancer Inst
98: 568-569
[Full Text]
Mansel, R. E., Fallowfield, L., Kissin, M., Goyal, A., Newcombe, R. G., Dixon, J. M., Yiangou, C., Horgan, K., Bundred, N., Monypenny, I., England, D., Sibbering, M., Abdullah, T. I., Barr, L., Chetty, U., Sinnett, D. H., Fleissig, A., Clarke, D., Ell, P. J.
(2006). Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.. JNCI J Natl Cancer Inst
98: 599-609
[Abstract][Full Text]
Cox, C., White, L., Allred, N., Meyers, M., Dickson, D., Dupont, E., Cantor, A., Ly, Q., Dessureault, S., King, J., Nicosia, S., Vrcel, V., Diaz, N.
(2006). Survival Outcomes in Node-Negative Breast Cancer Patients Evaluated With Complete Axillary Node Dissection Versus Sentinel Lymph Node Biopsy. Ann. Surg. Oncol.
13: 708-711
[Abstract][Full Text]
Bleiweiss, I. J., Nagi, C. S., Jaffer, S.
(2006). Axillary Sentinel Lymph Nodes Can Be Falsely Positive Due to Iatrogenic Displacement and Transport of Benign Epithelial Cells in Patients With Breast Carcinoma. JCO
24: 2013-2018
[Abstract][Full Text]
Houvenaeghel, G., Nos, C., Mignotte, H., Classe, J. M., Giard, S., Rouanet, P., Lorca, F. P., Jacquemier, J., Bardou, V. J.
(2006). Micrometastases in Sentinel Lymph Node in a Multicentric Study: Predictive Factors of Nonsentinel Lymph Node Involvement--Groupe Des Chirurgiens De La Federation Des Centres De Lutte Contre Le Cancer. JCO
24: 1814-1822
[Abstract][Full Text]
Wilke, L. G., McCall, L. M., Posther, K. E., Whitworth, P. W., Reintgen, D. S., Leitch, A. M., Gabram, S. G. A., Lucci, A., Cox, C. E., Hunt, K. K., Herndon, J. E. II, Giuliano, A. E.
(2006). Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial. Ann. Surg. Oncol.
13: 491-500
[Abstract][Full Text]
Abdul-Rasool, S, Kidson, S H, Panieri, E, Dent, D, Pillay, K, Hanekom, G S
(2006). An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes.. J. Clin. Pathol.
59: 289-297
[Abstract][Full Text]
Nathanson, S. D., Slater, R., DeBruyn, D., Kapke, A., Linden, M.
(2006). HER-2/neu Expression in Primary Breast Cancer With Sentinel Lymph Node Metastasis. Ann. Surg. Oncol.
13: 205-213
[Abstract][Full Text]
Bouknight, R. R., Bradley, C. J., Luo, Z.
(2006). Correlates of Return to Work for Breast Cancer Survivors. JCO
24: 345-353
[Abstract][Full Text]
International Breast Cancer Study Group,
(2006). Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of International Breast Cancer Study Group Trial 10-93. JCO
24: 337-344
[Abstract][Full Text]
Chou, H.-H., Chang, T.-C., Yen, T.-C., Ng, K.-K., Hsueh, S., Ma, S.-Y., Chang, C.-J., Huang, H.-J., Chao, A., Wu, T.-I, Jung, S.-M., Wu, Y.-C., Lin, C.-T., Huang, K.-G., Lai, C.-H.
(2006). Low Value of [18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Primary Staging of Early-Stage Cervical Cancer Before Radical Hysterectomy. JCO
24: 123-128
[Abstract][Full Text]
Rivers, A. K., Griffith, K. A., Hunt, K. K., Degnim, A. C., Sabel, M. S., Diehl, K. M., Cimmino, V. M., Chang, A. E., Lucas, P. C., Newman, L. A.
(2006). Clinicopathologic Features Associated With Having Four or More Metastatic Axillary Nodes in Breast Cancer Patients With a Positive Sentinel Lymph Node. Ann. Surg. Oncol.
13: 36-44
[Abstract][Full Text]
Smidt, M. L., Kuster, D. M., van der Wilt, G. J., Thunnissen, F. B., Van Zee, K. J., Strobbe, L. J. A.
(2005). Can the Memorial Sloan-Kettering Cancer Center Nomogram Predict the Likelihood of Nonsentinel Lymph Node Metastases in Breast Cancer Patients in The Netherlands?. Ann. Surg. Oncol.
12: 1066-1072
[Abstract][Full Text]
Davidson, N. E., Morrow, M., Kopans, D. B., Koerner, F. C.
(2005). Case 35-2005 -- A 56-Year-Old Woman with Breast Cancer and Isolated Tumor Cells in a Sentinel Lymph Node. NEJM
353: 2177-2185
[Full Text]
Intra, M., Trifiro, G., Viale, G., Rotmensz, N., Gentilini, O. D., Soteldo, J., Galimberti, V., Veronesi, P., Luini, A., Paganelli, G., Veronesi, U.
(2005). Second Biopsy of Axillary Sentinel Lymph Node for Reappearing Breast Cancer After Previous Sentinel Lymph Node Biopsy. Ann. Surg. Oncol.
12: 895-899
[Abstract][Full Text]
Lyman, G. H., Giuliano, A. E., Somerfield, M. R., Benson, A. B. III, Bodurka, D. C., Burstein, H. J., Cochran, A. J., Cody, H. S. III, Edge, S. B., Galper, S., Hayman, J. A., Kim, T. Y., Perkins, C. L., Podoloff, D. A., Sivasubramaniam, V. H., Turner, R. R., Wahl, R., Weaver, D. L., Wolff, A. C., Winer, E. P.
(2005). American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer. JCO
23: 7703-7720
[Abstract][Full Text]
Ryan, P. D., Kopans, D. B., Sgroi, D. C.
(2005). Case 24-2005 - A 58-Year-Old Woman with Early-Stage Estrogen-Receptor-Positive Breast Cancer. NEJM
353: 617-622
[Full Text]
Purushotham, A. D., Upponi, S., Klevesath, M. B., Bobrow, L., Millar, K., Myles, J. P., Duffy, S. W.
(2005). Morbidity After Sentinel Lymph Node Biopsy in Primary Breast Cancer: Results From a Randomized Controlled Trial. JCO
23: 4312-4321
[Abstract][Full Text]
Paganelli, G., Cremonesi, M., Ferrari, M., Trifiro, G., Gentilini, O., Luini, A.
(2005). Reply to the Letter to the Editor on Safety of sentinel node biopsy in pregnant patients, by G. Dubernard et al. (Ann Oncol 2005; 16: 987). Ann Oncol
16: 987-988
[Full Text]
Kawase, K., DiMaio, D. J., Tucker, S. L., Buchholz, T. A., Ross, M. I., Feig, B. W., Kuerer, H. M., Meric-Bernstam, F., Babiera, G., Ames, F. C., Singletary, S. E., Hunt, K. K.
(2005). Paget's Disease of the Breast: There Is a Role for Breast-Conserving Therapy. Ann. Surg. Oncol.
12: 391-397
[Abstract][Full Text]
Mamounas, E. P., Brown, A., Anderson, S., Smith, R., Julian, T., Miller, B., Bear, H. D., Caldwell, C. B., Walker, A. P., Mikkelson, W. M., Stauffer, J. S., Robidoux, A., Theoret, H., Sovan, A., Fisher, B., Wickerham, D. L., Wolmark, N.
(2005). Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27. JCO
23: 2694-2702
[Abstract][Full Text]
Mamounas, E. P.
(2005). Continuing Evolution in Breast Cancer Surgical Management. JCO
23: 1603-1606
[Full Text]
Colleoni, M., Rotmensz, N., Peruzzotti, G., Maisonneuve, P., Mazzarol, G., Pruneri, G., Luini, A., Intra, M., Veronesi, P., Galimberti, V., Torrisi, R., Cardillo, A., Goldhirsch, A., Viale, G.
(2005). Size of Breast Cancer Metastases in Axillary Lymph Nodes: Clinical Relevance of Minimal Lymph Node Involvement. JCO
23: 1379-1389
[Abstract][Full Text]
Classe, J.-M., Fiche, M., Rousseau, C., Sagan, C., Dravet, F., Pioud, R., Lisbona, A., Ferrer, L., Campion, L., Resche, I., Curtet, C.
(2005). Prospective Comparison of 3 {gamma}-Probes for Sentinel Lymph Node Detection in 200 Breast Cancer Patients. JNM
46: 395-399
[Abstract][Full Text]
Luini, A., Gatti, G., Ballardini, B., Zurrida, S., Galimberti, V., Veronesi, P., Vento, A. R., Monti, S., Viale, G., Paganelli, G., Veronesi, U.
(2005). Development of axillary surgery in breast cancer. Ann Oncol
16: 259-262
[Abstract][Full Text]
Smidt, M. L., Janssen, C. M. M., Kuster, D. M., Bruggink, E. D. M., Strobbe, L. J. A.
(2005). Axillary Recurrence After a Negative Sentinel Node Biopsy for Breast Cancer: Incidence and Clinical Significance. Ann. Surg. Oncol.
12: 29-33
[Abstract][Full Text]
Maggard, M. A., Lane, K. E., O'Connell, J. B., Nanyakkara, D. D., Ko, C. Y.
(2005). Beyond the Clinical Trials: How Often Is Sentinel Lymph Node Dissection Performed for Breast Cancer?. Ann. Surg. Oncol.
12: 41-47
[Abstract][Full Text]
Cappelletti, V., Celio, L., Bajetta, E., Allevi, A., Longarini, R., Miodini, P., Villa, R., Fabbri, A., Mariani, L., Giovanazzi, R., Galante, E., Greco, M., Grazia Daidone, M.
(2004). Prospective evaluation of estrogen receptor-{beta} in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients. Endocr Relat Cancer
11: 761-770
[Abstract][Full Text]
Nagata, H., Arai, T., Soejima, Y., Suzuki, H., Ishii, H., Hibi, T.
(2004). Limited Capability of Regional Lymph Nodes to Eradicate Metastatic Cancer Cells. Cancer Res.
64: 8239-8248
[Abstract][Full Text]
Colleoni, M., Rotmensz, N., Peruzzotti, G., Maisonneuve, P., Viale, G., Renne, G., Casadio, C., Veronesi, P., Intra, M., Torrisi, R., Goldhirsch, A.
(2004). Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies. Ann Oncol
15: 1633-1639
[Abstract][Full Text]
Rietman, J.S., Dijkstra, P.U., Geertzen, J.H. B., Baas, P., de Vries, J., Dolsma, W.V., Groothoff, J.W., Eisma, W.H., Hoekstra, H.J.
(2004). Treatment-Related Upper Limb Morbidity 1 Year after Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection for Stage I or II Breast Cancer. Ann. Surg. Oncol.
11: 1018-1024
[Abstract][Full Text]
Gentilini, O., Cremonesi, M., Trifiro, G., Ferrari, M., Baio, S. M., Caracciolo, M., Rossi, A., Smeets, A., Galimberti, V., Luini, A., Tosi, G., Paganelli, G.
(2004). Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol
15: 1348-1351
[Abstract][Full Text]